相关实验视频

Updated: Jul 19, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

对转移性黑色素瘤进行瘤性内溶性治疗

Danielle K DePalo¹, Matthew C Perez¹, Anne Huibers^2,3

¹Department of Cutaneous Oncology, Moffitt Cancer Center, 10920 McKinley Drive Room 4123, Tampa, FL, USA.

Clinical & experimental metastasis

|August 9, 2023

概括

黑色素瘤患者的转移性转移 (ITM) 可能是具有挑战性的手术治疗. 瘤病毒疗法,特别是基于疹病毒的疗法,通过向瘤细胞,提供了一个有前途的非手术治疗选择.

科学领域:

在瘤学瘤学.
病毒学病毒学
医学研究医学研究

背景情况:

过境转移 (ITM) 影响大约10%的黑色素瘤患者,由于大小,分布或解剖位置,通常会对手术切除提出挑战.
虽然手术是标准的,但不可切割的ITM需要替代治疗策略.
瘤性病毒疗法代表了IMT的重要非手术治疗方式.

研究的目的:

讨论瘤性病毒疗法的作用机制,用于治疗穿越性黑色素瘤转移.
审查有关两种最成熟的基于疹病毒的瘤治疗方法的现有文献.

主要方法:

文献综述侧重于基于疹病毒的结性病毒疗法.
分析包括瘤细胞溶解和全身抗瘤免疫反应诱导在内的机制.
对已知基于疹病毒的药物的治疗疗效和临床数据的检查.

主要成果:

瘤病毒选择性地感染并在瘤细胞内复制,导致细胞溶解.
病毒复制和细胞溶解触发了全身抗瘤免疫反应.
基于疹病毒的疗法已经在临床前和临床环境中证明了ITM治疗的潜力.

结论:

瘤性病毒疗法是手术无法切除的过渡性黑色素瘤的可行替代方案.
基于疹病毒的疗法是ITM最发达的非手术选择之一.
这些病毒病原体的进一步研究和临床应用有望改善黑色素瘤患者的治疗结果.

关键词:

内流性结性病毒疗法内流性疾病.黑色素瘤是一种黑色素瘤.发生转移的黑色素瘤.区域化疗是一种区域化疗.在区域转移性黑色素瘤.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...